Life Science REIT (LON:LABS) Trading 0.8% Higher – Time to Buy?

Shares of Life Science REIT plc (LON:LABS) shot up 0.8% on Friday . The stock traded as high as GBX 38.50 ($0.49) and last traded at GBX 38.50 ($0.49). 480,578 shares changed hands during trading, a decline of 51% from the average session volume of 990,415 shares. The stock had previously closed at GBX 38.20 ($0.48).

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on LABS shares. Jefferies Financial Group lowered their price target on Life Science REIT from GBX 45 ($0.57) to GBX 36 ($0.45) and set a “hold” rating for the company in a report on Friday, August 30th. Berenberg Bank reissued a “buy” rating and set a GBX 57 ($0.72) target price on shares of Life Science REIT in a research note on Thursday, October 3rd. Finally, Shore Capital reaffirmed a “buy” rating on shares of Life Science REIT in a research note on Thursday, September 26th.

Life Science REIT Trading Up 0.8 %

The company has a market capitalization of £134.75 million, a P/E ratio of -641.67 and a beta of 0.08. The firm’s 50 day moving average price is GBX 39.83 and its two-hundred day moving average price is GBX 36.09.

Life Science REIT Dividend Announcement

The firm also recently announced a dividend, which was paid on Thursday, October 31st. Investors of record on Thursday, October 3rd were given a GBX 1 ($0.01) dividend. This represents a yield of 3.11%. The ex-dividend date of this dividend was Thursday, October 3rd. Life Science REIT’s dividend payout ratio (DPR) is currently -3,333.33%.

About Life Science REIT

Life Science REIT plc (the Company) is a closed-ended Real Estate Investment Trust (REIT) incorporated in England and Wales on 27 July 2021. The Company began trading on 19 November 2021 and its shares are admitted to trading on the Premium Listing Segment of the Main Market of the London Stock Exchange.